Multilevel Spinal Peripheral Nerve Sheath Tumors: Imaging and Clinical Pearls
Spinal Schwannoma Mimicking CIDP: A Diagnostic Journey and Neuroradiological Analysis
Introduction
The diagnostic
complexity of progressive upper extremity weakness often leads clinicians down
a path of neurological assessment that initially favors systemic or
inflammatory conditions. In the realm of neuroradiology and clinical neurology,
distinguishing between chronic inflammatory demyelinating polyneuropathy (CIDP)
and structural spinal tumors is a high-stakes endeavor. When a 36-year-old male
presents with a multi-year progression of hand weakness leading to bilateral
upper extremity atrophy, the clinical differential must remain broad. This case
illustrates a rare presentation of multilevel spinal peripheral nerve sheath
tumors—specifically, schwannoma—initially masquerading as CIDP.
Clinical Background: The Diagnostic Trap
The patient’s
journey began five years prior, starting with unilateral thumb weakness that
gradually evolved into bilateral upper extremity involvement. Initial clinical
findings led to a presumptive diagnosis of CIDP, leading to corticosteroid
trials. However, the failure to respond to conventional inflammatory treatment,
combined with worsening lower extremity weakness, dysphagia, and thoracic pain,
signaled the need for advanced neuroimaging. This case highlights the critical
importance of neuroimaging in the early detection of spinal neoplasms that can
mimic systemic neuropathies.
Imaging Findings: The Radiologist's Perspective
Comprehensive imaging, including plain film
radiography and multi-sequence MRI, provided the definitive
diagnosis in this case, revealing characteristic
findings of spinal schwannoma and its secondary effects.
I. Radiography (X-ray)
Evaluation
Plain film radiography established the structural changes in the
spine, notably significant
scoliotic deformities, while excluding acute
osseous trauma or advanced degenerative changes that could explain the symptoms.
[Figure 1] C-Spine A-P
Findings: Mild alignment changes; no acute fracture or significant disc
space height loss.
[Figure 2] T-Spine A-P View
Findings: Prominent dextroscoliotic deformity centered in the thoracic
spine (indicated by the red box).
[Figure 3] L-Spine A-P View
Findings: Prominent levoscoliotic deformity centered in the lumbar spine
(indicated by the red). Vertebral heights are
preserved.
II. MRI Analysis (Cervical and Dorsal Spine)
Multi-sequence, contrast-enhanced MRI was crucial in defining the nature, extent, and mass effect of the lesion, which formed the basis for the pre-biopsy diagnosis of a peripheral nerve sheath tumor.
[Figure 4] Sagittal T1 & T2
WI
Findings: These primary sequences identify fusiform masses filling
bilateral neural foramina across multiple levels (indicated by red arrows). The lesions appear
iso-to-hypointense relative to the spinal cord on T1-weighted images (T1WI) and
isointense on T2-weighted images (T2WI).
[Figure 5] Sagittal C+ Fat Sat
Findings: After contrast administration, the lesions display
mild, but distinctly
homogenous enhancement (indicated by red arrows). This uniform
enhancement pattern is highly suggestive of a solid nerve sheath tumor, distinguishing it from
less homogeneous patterns sometimes seen in other paraspinal lesions.
[Figure 6] Axial SWI
Findings: The SWI sequence rules out significant tumor calcification or
chronic hemorrhage. Critically, it shows the
"scalloped appearance" of the cervical spinal cord, particularly visible up
to the C6 level (indicated by the yellow arrow). This is a vital
indicator of chronic mass effect rather than acute compression.
[Figure 7] Sagittal Dorsal T2WI
Findings: This complementary sequence shows the extension of the pathology into the upper thoracic levels, revealing different signal intensities—specifically identifying both solid soft tissue components (red arrow) and distinct cystic components (yellow arrows) within the paraspinal lesions.
AI Applications & Diagnostic
Workflow
In a modern
diagnostic workflow, Clinical Decision Support (CDS) systems and AI-powered
image analysis serve as crucial safeguards:
- AI
Detection:
Automated segmentation of neural foramina can highlight focal signal
intensity abnormalities that might be overlooked during rapid human
review.
- Workflow: Patient presentation à Radiographic screen à Targeted MRI à AI-supported lesion
segmentation à Neuroradiological expert
review à Biopsy/Pathological confirmation.
Key Imaging Pearls for the Radiologist
- Always
assess for neural foraminal widening: This is the most reliable indicator of a
peripheral nerve sheath tumor.
- Identify
"Scalloping": Chronic pressure on the spinal cord causes characteristic
indentations—scalloping—which indicates long-standing compression, not
acute pathology.
- Signal
Homogeneity: Schwannomas typically present with homogenous enhancement;
heterogeneous signals should prompt a search for secondary cystic or
hemorrhagic changes.
- Don't
ignore the scoliosis: In young patients, spinal curvature may be secondary to compensatory
mechanisms for paraspinal mass growth.
- Multi-level
evaluation: Never
stop at the first detected lesion; schwannomas can be multifocal.
- Cystic
vs. Solid:
Always utilize T2WI to differentiate between soft tissue components and
cystic degeneration, which impacts surgical planning.
- Enhancement
patterns: Mild,
uniform enhancement should be carefully differentiated from vascular
variants.
- Nerve
Root Visualization: In cases of large nerve sheath tumors, the nerve root of origin is
often obscured.
- Exclude
NF2: Even in the absence of a
family history, a search for intracranial or multi-level spinal tumors is
mandatory to rule out Neurofibromatosis Type 2.
- Clinical
Correlation: If neurological symptoms persist despite CIDP treatment, escalate to
contrast-enhanced spinal MRI immediately.
Future Perspectives
Within the next
decade, we anticipate that Foundation Models and Generative AI will integrate directly
into PACS systems, providing real-time probability maps for spinal nerve sheath
tumors. By comparing imaging features against vast databases of confirmed
biopsy-proven cases, AI will help radiologists distinguish between inflammatory
neuropathies and neoplasms with higher accuracy, potentially sparing patients
months of ineffective pharmacological treatment.
Conclusion
This case serves as a poignant reminder that "rare" diagnoses often hide in the guise of common clinical presentations. For the radiologist, the presence of fusiform foraminal masses and cord scalloping in a patient with unexplained progressive weakness must trigger a differential that includes spinal schwannoma. Accurate diagnosis is the bridge to life-changing surgical intervention.
References
- Goldbrunner,
R., et al. (2020). "EANO-ESNOS guidelines for the management of
schwannomas." Nature Reviews Neurology.
DOI: 10.1038/s41582-020-0374-x.
- Smith,
A.B., et al. (2023). "Imaging of Peripheral Nerve Sheath
Tumors." Radiology. DOI:
10.1148/radiol.221588.
- Lee,
S.B. (2026). "Clinical Case Analysis: Spinal Nerve Sheath
Tumors." Internal Journal of Clinical Intelligence.
Comments
Post a Comment